Cargando…
Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting
The systemic application of highly potent drugs such as cytostatics poses the risks of side effects, which could be reduced by using a carrier system able to specifically deliver the encapsulated drug to the target tissue. Essential components of a nanoparticle-based drug delivery system include the...
Autores principales: | Lizoňová, Denisa, Majerská, Monika, Král, Vlastimil, Pechar, Michal, Pola, Robert, Kovář, Marek, Štěpánek, František |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081219/ https://www.ncbi.nlm.nih.gov/pubmed/35541757 http://dx.doi.org/10.1039/c8ra03487g |
Ejemplares similares
-
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo
por: Studenovský, Martin, et al.
Publicado: (2022) -
Feasibility and constraints of particle targeting using the antigen–antibody interaction
por: Tokárová, Viola, et al.
Publicado: (2013) -
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021) -
In Vitro and In Vivo Studies on HPMA-Based Polymeric Micelles Loaded with Curcumin
por: Bagheri, Mahsa, et al.
Publicado: (2021) -
Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells
por: Kalousková, Barbora, et al.
Publicado: (2021)